Acasti Pharma Inc
XTSX:ACST
Acasti Pharma Inc
XTSX:ACST
Price:
0.58
CAD
1.75%
Market Closed
Market Cap:
CA$25.9m
Balance Sheet
Balance Sheet Decomposition
Acasti Pharma Inc
Acasti Pharma Inc
Balance Sheet Decomposition is not available for
Acasti Pharma Inc
Acasti Pharma Inc
Balance Sheet
Acasti Pharma Inc
Acasti Pharma Inc
Currency: USD
| Mar-2021 | Mar-2022 | Mar-2023 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
51
|
30
|
28
|
|
| Cash Equivalents |
51
|
30
|
28
|
|
| Short-Term Investments |
10
|
13
|
0
|
|
| Total Receivables |
1
|
1
|
1
|
|
| Other Current Assets |
1
|
1
|
1
|
|
| Total Current Assets |
62
|
45
|
29
|
|
| PP&E Net |
0
|
1
|
1
|
|
| Intangible Assets |
0
|
70
|
41
|
|
| Goodwill |
0
|
13
|
8
|
|
| Other Assets |
0
|
13
|
8
|
|
| Total Assets |
62
N/A
|
129
+106%
|
79
-38%
|
|
| Liabilities | ||||
| Accounts Payable |
1
|
2
|
2
|
|
| Accrued Liabilities |
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
3
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
17
|
7
|
|
| Other Liabilities |
5
|
0
|
0
|
|
| Total Liabilities |
7
N/A
|
20
+199%
|
11
-45%
|
|
| Equity | ||||
| Common Stock |
197
|
258
|
258
|
|
| Retained Earnings |
146
|
156
|
198
|
|
| Additional Paid In Capital |
11
|
12
|
14
|
|
| Other Equity |
6
|
6
|
6
|
|
| Total Equity |
56
N/A
|
108
+95%
|
68
-37%
|
|
| Total Liabilities & Equity |
62
N/A
|
129
+106%
|
79
-38%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
4
|
7
|
7
|
|
Switch to:
Switch to:
See Also
Discover More
